Drug Discovery Instruments
| Distribution of Bioresource Materials from ATCC | Drug Discovery Instruments
| Drug Discovery Research Alliance Arrangement | Licensing of Drugs, Drug Candidates & Diagnostics |
| API & Intermediate Business | Formulation Business | Regulatory Service |

Introducing the world's most advanced biotechnology.
IMPORT/DISTRIBUTE BIOTECH INSTRUMENTS, REAGENTS & SERVICES

We import the latest biotech instruments and reagents that assist drug discoveries from all over the world and distribute to Japanese market in order to help enhance efficiency of research in Japan. We provide each customer with comprehensive and flexible services to fulfill their individual needs.

In order to provide wider services to Japanese customers, SPI has merged SCBioSciences business unit from April 1st 2006.

Address
BioScience Department, Summit Pharmaceuticals International Corporation
Harumi Island Triton Square Office Tower Z, 1-8-12
Harumi, Chuo-ku, Tokyo 104-6223, Japan
Tel: +81-3-3536-8720
Fax: +81-3-3536-8725
E-mail:


Global Strategy

Current Business Challenges

  • Lack of business skills and global network among Japanese biotechnology companies.

  • Instrument manufacturers do not necessarily have experience and expertise to enter biotechnology market.
↓
Sumitomo's global network can provide solutions to Japanese biotechnology companies and our global partners.
SPI's role as a business organizer is very important for both groups.


Role as a business organizer
SPI utilizes SC's global network to help solve the business problems of companies all over the world.

Challenges Solutions
Typical Japanese biotechnology
companies
  • Lack international business skills.
  • Lack a global network.
 SPI will help find partners in the world.
SPI will help with negotiations.
North American
and
European companies
  • Lack of information about the Japanese market.
  • Negotiation with Japanese companies is difficult.
 SPI will evaluate the needs and find the right partner in Japan.
Investors
outside Japan
  • Lack of information about Japan.
  • Difficulty in attending board meetings.
 If SPI co-invests, SPI can represent the investor.


Partners & Relationship

SPI's Selected Overseas Partners
SPI represents companies overseas and distributes their products in Japan.

Drug discovery tools (Instrument
and Reagent)
  • Provide field maintenance & scientific support locally.
  • Carry out pilot projects in Japan.
  • Develop our own assay-kits.
Xenogen, Cyntellect, MaunaKea Technologies, Biotage, Genvault, Pneumatic scale
Platform technology
and service
  • Collaboration support.
  • Promote the technology.
 Metabolon, Qualyst, RBC, Multispan


Deal making process for distribution partnership

Initial interaction
 ~ 1 month Introduction to each other, understand the needs of each party.
Technology evaluation
 1~2 months Involve scientists to evaluate the technology. Evaluate the uniqueness, the fit in the current partners.
Feasibility
study
 1~4 months
 Take the science and technology to Japanese pharmaceutical companies. Evaluate the Japanese market segment size. Forecast the sales of the instrument or technology.
Discussion
 1~3 months Decide the form of the relationship (commitment, prepayment, investment.)
Final stage
 Total 3~8 months
 Distribution agreement, strategic investment (in some cases.)